Langzeit-Follow-up von Patientinnen nach ovarieller Stimulation und Kinderwunschtherapien

  • Michael LudwigEmail author
Part of the Springer Reference Medizin book series (SRM)


Es wird häufig von Patientinnen und ihren Partnern nach möglichen Langzeitschäden einer Kinderwunschbehandlung bzw. einer Hormonstimulation gefragt. In diesem Kapitel sollen kurzfristige, mittelfristige und langfristige Risiken behandelt werden. Dabei wird neben den somatischen Aspekten auch die familiäre Gesundheit anhand der verfügbaren Literatur dargestellt.


  1. Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, Brinton LA (2005a) Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161:607–615PubMedCrossRefPubMedCentralGoogle Scholar
  2. Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA (2005b) Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 193:668–674PubMedCrossRefPubMedCentralGoogle Scholar
  3. Balen F van (1998) Development of IVF children. Dev Rev 18:30–46Google Scholar
  4. Barnes J, Sutcliffe AG, Kristoffersen I, Loft A, Wennerholm U, Tarlatzis BC, Kantaris X, Nekkebroeck J, Hagberg BS, Madsen SV et al (2004) The influence of assisted reproduction on family functioning and children’s socio-emotional development: results from a European study. Hum Reprod 19:1480–1487PubMedCrossRefPubMedCentralGoogle Scholar
  5. Bjornholt SM, Krüger Kjaer S, Nielsen TSS, Jensen A (2015) Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study. Hum Reprod 30:222–231PubMedCrossRefPubMedCentralGoogle Scholar
  6. Boer EJ de, den Tonkelaar I, Te Velde ER, Burger CW, Klip H, van Leeuwen FE (2002) A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 77:978–985Google Scholar
  7. Boer EJ de, den Tonkelaar I, Te Velde ER, Burger CW, van Leeuwen FE (2003) Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18:1544–1552Google Scholar
  8. Boer EJ de, den Tonkelaar I, Burger CW, Looman CW, van Leeuwen FE, Te Velde ER (2004) The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles. Hum Reprod 19:899–904Google Scholar
  9. Braat DD, Bernardus RE, Gerris J (2002) Anonymous reports of lethal cases of ovarian hyperstimulation syndrome. In: Gerris J, Delvigne A, Olivennes F (Hrsg) Ovarian hyperstimulation syndrome. Informa UK, London, S 59–66Google Scholar
  10. Braat DD, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE (2010) Maternal death related to IVF in the Netherlands 1984–2008. Hum Reprod 25:1782–1786PubMedCrossRefPubMedCentralGoogle Scholar
  11. Brinton LA, Moghissi KS, Scoccia B, Westhoff CL Lamb EJ (2005) Ovulation induction and cancer risk. Fertil Steril 83:261–274PubMedCrossRefPubMedCentralGoogle Scholar
  12. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, Moghissi KS (2013) Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod 28:2813–2821PubMedPubMedCentralCrossRefGoogle Scholar
  13. Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff CL (2015) Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril 104:980–988PubMedPubMedCentralCrossRefGoogle Scholar
  14. Bryson CA, Sykes DH, Traub AI (2000) In vitro fertilization: a long-term follow-up after treatment failure. Hum Fertil (Cambridge) 3:214–220CrossRefGoogle Scholar
  15. Cetin I, Cozzi V, Antonazzo P (2008) Infertility as a cancer risk factor – a review. Placenta 29(Suppl B):169–177PubMedCrossRefGoogle Scholar
  16. Elder K, Mathews T, Kutner E, Kim E, Espenberg D, Faddy M, Gosden R (2008) Impact of gonadotrophin stimulation for assisted reproductive technology on ovarian ageing and menopause. Reprod Biomed Online 16:611–616PubMedCrossRefGoogle Scholar
  17. Filetto JN, Makuch MY (2005) Long-term follow-up of women and men after unsuccessful IVF. Reprod Biomed Online 11:458–463PubMedCrossRefGoogle Scholar
  18. Golombok S (2000) Parenting – what really counts? Taylor & Francis Group, London/PhiladelphiaGoogle Scholar
  19. Golombok S, Brewaeys A, Cook R, Giavazzi MT, Guerra D, Mantovani A, van HE, Crosignani PG, Dexeus S (1996) The European study of assisted reproduction families: family functioning and child development. Hum Reprod 11:2324–2331PubMedCrossRefGoogle Scholar
  20. Hammarberg K, Astbury J, Baker H (2001) Women’s experience of IVF: a follow-up study. Hum Reprod 16:374–383PubMedCrossRefPubMedCentralGoogle Scholar
  21. Hannibal CG, Jensen A, Sharif H, Kjaer SK (2008) Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 23:451–456PubMedCrossRefPubMedCentralGoogle Scholar
  22. Hjelmstedt A, Widstrom A, Wramsby HM, Collins A (2003a) Patterns of emotional responses to pregnancy, experience of pregnancy and attitudes to parenthood among IVF couples: a longitudinal study. J Psychosom Obstet Gynaecol 24:153–162PubMedCrossRefPubMedCentralGoogle Scholar
  23. Hjelmstedt A, Widstrom AM, Wramsby H, Matthiesen AS, Collins A (2003b) Personality factors and emotional responses to pregnancy among IVF couples in early pregnancy: a comparative study. Acta Obstet Gynecol Scand 82:152–161PubMedCrossRefPubMedCentralGoogle Scholar
  24. Jensen A, Sharif H, Frederiksen K, Kjaer SK (2009) Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study. BMJ 338:b249PubMedPubMedCentralCrossRefGoogle Scholar
  25. Kashyap S, Moher D, Fung MF, Rosenwaks Z (2004) Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet Gynecol 103:785–794PubMedCrossRefPubMedCentralGoogle Scholar
  26. Klip H (2002) Long-term health effects of subfertility treatment, the Netherlands. PrintPartners Ipskamp, EnschedeGoogle Scholar
  27. Klip H, van Leeuwen FE, Schats R, Burger CW (2003) Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women. Hum Reprod 18:1951–1958PubMedCrossRefPubMedCentralGoogle Scholar
  28. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW (1990) An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1:223–234PubMedCrossRefPubMedCentralGoogle Scholar
  29. Kristiansson P, Bjor O, Wramsby H (2007) Tumour incidence in Swedish women who gave birth following IVF treatment. Hum Reprod 22:421–426PubMedCrossRefPubMedCentralGoogle Scholar
  30. Kvaskoff M, Bijon A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011) Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. Am J Epidemiol 173(10):1192–1202PubMedCrossRefPubMedCentralGoogle Scholar
  31. La Vecchia C, Ron E, Franceschi S, Dal ML, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L et al (1999) A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157–166PubMedCrossRefPubMedCentralGoogle Scholar
  32. Leiblum SR, Aviv A, Hamer R (1998) Life after infertility treatment: a long-term investigation of marital and sexual function. Hum Reprod 13:3569–3574PubMedCrossRefPubMedCentralGoogle Scholar
  33. Litt MD, Tennen H, Affleck G, Klock S (1992) Coping and cognitive factors in adaptation to in vitro fertilization failure. J Behav Med 15:171–187PubMedCrossRefPubMedCentralGoogle Scholar
  34. Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, Koch L, Smith Y, Stern JE, Ball GD, Schymura MJ (2015) Cancer in women after assisted reproductive technology. Fertil Steril 104:1218–1226PubMedPubMedCentralCrossRefGoogle Scholar
  35. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, Freedman L, Mashiach S, Lunenfeld B (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147:1038–1042PubMedCrossRefPubMedCentralGoogle Scholar
  36. Newton CR, Hearn MT, Yuzpe AA (1990) Psychological assessment and follow-up after in vitro fertilization: assessing the impact of failure. Fertil Steril 54:879–886PubMedCrossRefGoogle Scholar
  37. Owen L, Golombok S (2009) Families created by assisted reproduction: parent-child relationships in late adolescence. J Adolesc 32:835–848PubMedCrossRefGoogle Scholar
  38. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331:771–776PubMedCrossRefGoogle Scholar
  39. Schröder AK, Katalinic A, Diedrich K, Ludwig M (2004) Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online 8:600–606PubMedCrossRefGoogle Scholar
  40. Sergentanis TN, Diamantaras A-A, Perlepe C, Kanavidis P, Skalkidou A, Petridou ET (2014) IVF and breast cancer: a systematic review and meta-analysis. Hum Reprod Update 20:106–123PubMedCrossRefPubMedCentralGoogle Scholar
  41. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG (1996) Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 65:13–18PubMedCrossRefPubMedCentralGoogle Scholar
  42. Slade P, Emery J, Lieberman BA (1997) A prospective, longitudinal study of emotions and relationships in in-vitro fertilization treatment. Hum Reprod 12:183–190PubMedCrossRefPubMedCentralGoogle Scholar
  43. Spaan M, van den Belt-Dusebout AW, Schaapveld M, Mooij TM, Burger CW, van Leeuwen FE, on Behalf of the OMEGA-Project Group (2015) Melanoma risk after ovarian stimulation for in vitro fertilization. Hum Reprod 30:1216–1228PubMedCrossRefPubMedCentralGoogle Scholar
  44. Sydsjo G, Svanberg AS, Lampic C, Jablonowska B (2011) Relationships in IVF couples 20 years after treatment. Hum Reprod 26:1836PubMedCrossRefPubMedCentralGoogle Scholar
  45. Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff C, Niwa S, Brinton LA (2013) Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large US infertility cohort. Fertil Steril 100:1660–1666PubMedCrossRefPubMedCentralGoogle Scholar
  46. Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354:1586–1590PubMedCrossRefPubMedCentralGoogle Scholar
  47. Venn A, Hemminki E, Watson L, Bruinsma F, Healy D (2001) Mortality in a cohort of IVF patients. Hum Reprod 16:2691–2696PubMedCrossRefPubMedCentralGoogle Scholar
  48. Weaver SM, Clifford E, Hay DM, Robinson J (1997) Psychosocial adjustment to unsuccessful IVF and GIFT treatment. Patient Educ Couns 31:7–18PubMedCrossRefPubMedCentralGoogle Scholar
  49. Whittemore AS (1993) Fertility drugs and risk of ovarian cancer. Hum Reprod 8:999–1000PubMedCrossRefPubMedCentralGoogle Scholar
  50. Wirtberg I, Moller A, Hogstrom L, Tronstad SE, Lalos A (2007) Life 20 years after unsuccessful infertility treatment. Hum Reprod 22:598–604PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.SYNLAB Holding Deutschland GmbHAugsburgDeutschland

Personalised recommendations